1. Home
  2. CTKB vs LEO Comparison

CTKB vs LEO Comparison

Compare CTKB & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.44

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Logo BNY Mellon Strategic Municipals Inc.

LEO

BNY Mellon Strategic Municipals Inc.

HOLD

Current Price

$6.47

Market Cap

404.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
LEO
Founded
1990
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
652.1M
404.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CTKB
LEO
Price
$4.44
$6.47
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$5.70
N/A
AVG Volume (30 Days)
772.6K
176.6K
Earning Date
05-20-2026
01-01-0001
Dividend Yield
N/A
4.01%
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
$193,015,000.00
N/A
Revenue This Year
$4.82
N/A
Revenue Next Year
$8.36
N/A
P/E Ratio
N/A
$163.25
Revenue Growth
17.67
N/A
52 Week Low
$2.37
$5.67
52 Week High
$6.18
$6.55

Technical Indicators

Market Signals
Indicator
CTKB
LEO
Relative Strength Index (RSI) 40.72 51.24
Support Level $4.00 $6.20
Resistance Level $5.24 $6.55
Average True Range (ATR) 0.23 0.05
MACD 0.04 -0.00
Stochastic Oscillator 63.11 56.25

Price Performance

Historical Comparison
CTKB
LEO

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About LEO BNY Mellon Strategic Municipals Inc.

BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products include equity and fixed income mutual funds, retail money market funds, government/treasury money market funds, institutional money market funds, and others. The company and its affiliates, as well as others involved in the management, sales, investment activities, business operations, or distribution of the fund, are engaged in businesses and have interests other than those of managing the fund.

Share on Social Networks: